Answers are grounded in this paper and cite their sources.
The morbidity and mortality of pediatric asthma continue to be significant in the United States. This article discusses the rationale for the National Heart, Lung, and Blood Institute Guidelines issued in 1991 and 1997, and uses them as a basis for treating the acute asthma exacerbation in a child. Newer modalities of treatment are discussed with particular attention to the use of continuous nebulization of beta agonists, inhalation of ipratroprium bromide, heliox, terbutaline infusions and magnesium sulfate. Both the scientific support for the current management of asthma and the practical aspects of clinical management are reviewed.
No takes yet. Share an insight, caveat, or question.
Élise W. van der Jagt (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: